Screener
Charles River Laboratories CRL Segment operating income — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Cost of products sold (excluding amortization of intangible assets) | 88,697 | 90,192 | 180,956 | 179,200 |
| Selling, general and administrative | 228,897 | 191,549 | 388,319 | 369,348 |
| Amortization of intangible assets | 14,589 | 65,384 | 29,934 | 130,648 |
| Operating income | 119,888 | 100,134 | 239,785 | 174,803 |
| Other income (expense) | ||||
| Interest income | 1,032 | 1,097 | 2,065 | 2,501 |
| Interest expense | (30,340) | (29,967) | (57,082) | (57,851) |
| Other (expense) income, net | (37,410) | 154 | (161,540) | (12,057) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's segment operating income — operating income (loss)?
- Charles River Laboratories (CRL) reported segment operating income — operating income (loss) of $226.28M in Q2 2026.
- How has Charles River Laboratories's segment operating income — operating income (loss) changed year-over-year?
- Charles River Laboratories's segment operating income — operating income (loss) increased by 32.6% year-over-year, from $170.63M to $226.28M.
- What does segment operating income — operating income (loss) mean?
- This metric represents the profit or loss generated by a specific business segment after deducting direct operating expenses, including cost of services and segment-specific selling, general, and administrative costs. It serves as a primary indicator of the operational efficiency and profitability of a distinct business unit before the allocation of corporate overhead or interest and tax expenses. Investors use this to evaluate the performance of individual business lines independent of the broader corporate structure.
Ask your AI about Charles River Laboratories's segment operating income — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude